Table 2 Immunohistochemical analysis of patients with oral BSCC, W/MSCC and PDSCC
Antibodies | No. of cases (%) | ||||||
|---|---|---|---|---|---|---|---|
BSCC | PDSCC | W/MSCC | p value* | ||||
E-cadherin | |||||||
Weak immunostaining | 15 | 88.2 | 21 | 80.8 | 15 | 53.6 | .019 |
Strong immunostaining | 2 | 11.8 | 5 | 19.2 | 13 | 46.4 | |
β-catenin | |||||||
Weak immunostaining | 10 | 58.8 | 20 | 76.9 | 20 | 71.4 | .355 |
Strong immunostaining | 7 | 41.2 | 6 | 23.1 | 8 | 28.6 | |
Total | 17 | 100 | 26 | 100 | 28 | 100 | |